Multi-Resistant Pathogens

This emerging threat brings further challenges for the patient and the healthcare professionals treating the condition.

Enhanced Antibiotic Functionalisation

Building on the OSTEOmycin® clinical experience, we now provide Zenith products. These are an enhanced range of functionalised processed allografts to address the multi resistant pathogen challenge.